FDA Approved: DABIGATRAN ETEXILATE — Original Application (Major Pharmaceuticals)

View source ↗

Summary

FDA approved the original application for dabigatran etexilate from Major Pharmaceuticals, approving a generic version of the anticoagulant and listing its indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Nonvalvular Atrial Fibrillation
• Pulmonary Embolism

Drugs mentioned

• Dabigatran etexilate (Dabigatran etexilate)

Snippet

ORIG AP for DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE)